News

Stay informed on our most recent announcements, achievements, and developments in advancing patient care.

Mary Ellis 12/15/25 Mary Ellis 12/15/25

Today's Medical Developments publishes on amnion in med devices

Peytant's Medical Director Win Froelich discusses role of amnion in next-gen devices

Mary Ellis 12/8/25 Mary Ellis 12/8/25

CEO Schorgl quoted in MD+DI’s look ahead at 2026

John Schorgl shares insights on 2026 medtech trends in Medical Device and Diagnostic Industry (MD+DI) article “The Medtech Landscape in 2026: Here’s What to Expect.”

Mary Ellis 12/3/25 Mary Ellis 12/3/25

CEO Schorgl featured in Medical Design & Outsourcing

Peytant’s CEO shares insights on navigating the de novo process in recent MD&O article

Mark Edwards 8/29/25 Mark Edwards 8/29/25

Medical Design & Outsourcing features Peytant

MD&O, in its latest article, discusses how Peytant Solutions combined proven materials to yield a first-of-a-kind stent.

Mark Edwards 8/27/25 Mark Edwards 8/27/25

Positive pre-clinical results presented at AABIP

Peytant Solutions, Inc. announced the presentation of positive pre-clinical results at AABIP.

Alexander Rollins 8/5/25 Alexander Rollins 8/5/25

Peytant presents at AABIP 2025

Peytant Solutions Inc. will present new research at the 2025 AABIP Annual Meeting.

Alexander Rollins 1/27/25 Alexander Rollins 1/27/25

Peytant names Walker CMO

Peytant Solutions Inc. announces the appointment of Craig Walker, MD as Chief Medical Officer.

Alexander Rollins 10/22/24 Alexander Rollins 10/22/24

Peytant granted FDA De Novo

Peytant Solutions, Inc. announced the FDA granted marketing authorization for the AMStent System, a novel, proprietary therapy platform.